MedPath

AVACTA GROUP PLC

AVACTA GROUP PLC logo
🇬🇧United Kingdom
Ownership
Public
Established
2003-01-01
Employees
51
Market Cap
$356.2M
Website
http://www.avacta.com

Avacta's AVA6000 Shows Durable Responses in FAP-Positive Solid Tumors with Reduced Toxicity

AVA6000 demonstrates encouraging efficacy with durable RECIST responses in patients with FAP-positive solid tumors, aligning with a favorable safety profile.

© Copyright 2025. All Rights Reserved by MedPath